DNA cross linking agent

DRUG CLASS:

DNA cross linking agent

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	idarubicin hydrochloride Sensitive: A1 - Approval idarubicin hydrochloride Sensitive : A1	idarubicin hydrochloride Sensitive: A1 - Approval idarubicin hydrochloride Sensitive : A1
No biomarker	Colon Cancer	No biomarker	Colon Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Pancreatic Cancer	No biomarker	Pancreatic Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
HER-2 negative	Gastroesophageal Junction Adenocarcinoma	HER-2 negative	Gastroesophageal Junction Adenocarcinoma	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
HER-2 negative	Gastric Cancer	HER-2 negative	Gastric Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	gemcitabine + paclitaxel + oxaliplatin Sensitive: A2 - Guideline gemcitabine + paclitaxel + oxaliplatin Sensitive : A2	gemcitabine + paclitaxel + oxaliplatin Sensitive: A2 - Guideline gemcitabine + paclitaxel + oxaliplatin Sensitive : A2
No biomarker	Gallbladder Cancer	No biomarker	Gallbladder Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Gastric Cancer	No biomarker	Gastric Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Gastroesophageal Junction Adenocarcinoma	No biomarker	Gastroesophageal Junction Adenocarcinoma	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Esophageal Cancer	No biomarker	Esophageal Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Gastroesophageal Junction Adenocarcinoma	No biomarker	Gastroesophageal Junction Adenocarcinoma	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2
No biomarker	Esophageal Cancer	No biomarker	Esophageal Cancer	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2
No biomarker	Biliary Tract Cancer	No biomarker	Biliary Tract Cancer	gemcitabine + oxaliplatin Sensitive: A2 - Guideline gemcitabine + oxaliplatin Sensitive : A2	gemcitabine + oxaliplatin Sensitive: A2 - Guideline gemcitabine + oxaliplatin Sensitive : A2
No biomarker	Biliary Tract Cancer	No biomarker	Biliary Tract Cancer	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2	5-fluorouracil + oxaliplatin Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin Sensitive : A2
No biomarker	Neuroendocrine Tumor	No biomarker	Neuroendocrine Tumor	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Gastroesophageal Junction Adenocarcinoma	No biomarker	Gastroesophageal Junction Adenocarcinoma	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
No biomarker	Esophageal Cancer	No biomarker	Esophageal Cancer	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2	oxaliplatin Sensitive: A2 - Guideline oxaliplatin Sensitive : A2
HER-2 negative	Esophageal Cancer	HER-2 negative	Esophageal Cancer	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive : A2	cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride Sensitive : A2	cytarabine + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride Sensitive : A2
No biomarker	Colon Cancer	No biomarker	Colon Cancer	5-fluorouracil + oxaliplatin + leucovorin calcium Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin + leucovorin calcium Sensitive : A2	5-fluorouracil + oxaliplatin + leucovorin calcium Sensitive: A2 - Guideline 5-fluorouracil + oxaliplatin + leucovorin calcium Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	clofarabine + idarubicin hydrochloride Sensitive: A2 - Guideline clofarabine + idarubicin hydrochloride Sensitive : A2	clofarabine + idarubicin hydrochloride Sensitive: A2 - Guideline clofarabine + idarubicin hydrochloride Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	cytarabine + methotrexate + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + methotrexate + idarubicin hydrochloride Sensitive : A2	cytarabine + methotrexate + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + methotrexate + idarubicin hydrochloride Sensitive : A2
No biomarker	Biliary Tract Cancer	No biomarker	Biliary Tract Cancer	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2
HER-2 negative	Gastric Cancer	HER-2 negative	Gastric Cancer	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2	capecitabine + oxaliplatin Sensitive: A2 - Guideline capecitabine + oxaliplatin Sensitive : A2
KRAS wild-type	Pancreatic Ductal Adenocarcinoma	KRAS wild-type	Pancreatic Ductal Adenocarcinoma	5-fluorouracil + oxaliplatin Sensitive: B - Late Trials 5-fluorouracil + oxaliplatin Sensitive : B	5-fluorouracil + oxaliplatin Sensitive: B - Late Trials 5-fluorouracil + oxaliplatin Sensitive : B

DNA cross linking agent

DNA cross linking agent

Associations(75)

Associations
(75)